5 months ago
NBIX
AnalystsLaura ChicoLaura Chico's Stock Forecasts
AnalystsLaura Chico
Analyst Ranking
Top 4%
#167 out of 5313 analysts
Average Return
+19.44%
Win Rate
52%128 out of 247
Risk vs Reward
Poor
Good
Laura Chico's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Longboard Pharmaceuticals IncLBPH | +658.28% | $5.13 | $38.90 | 2023-10-12 - 2024-10-11 | Buy |
Edgewise Therapeutics IncEWTX | +560.25% | $5.51 | $36.38 | 2023-11-10 - 2024-11-08 | Buy |
Dianthus Therapeutics IncDNTH | +357.27% | $18.84 | $86.15 | 2025-05-13 - 2026-05-12 | Buy |
Ovid Therapeutics IncOVID | +314.00% | $0.50 | $2.07 | 2025-03-12 - 2026-03-11 | Buy |
Dianthus Therapeutics IncDNTH | +291.96% | $21.90 | $85.84 | 2025-03-12 - 2026-03-11 | Buy |
Laura Chico Analyst Color
Get additional color on Laura Chico's coverage of popular stocks
2 years ago
ARDX
Laura Chico's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Viridian Therapeutics IncVRDN | 12 | Buy | $43.00 | +132.68% | Maintains | 2 days ago |
Travere Therapeutics IncTVTX | 16 | Buy | $61.00 | +8.27% | Maintains | 10 days ago |
Climb Bio IncCLYM | 4 | Buy | $17.00 | +27.92% | Reiterates | 20 days ago |
Praxis Precision Medicines IncPRAX | 14 | Sell | $162.00 | -49.31% | Maintains | a month ago |
Edgewise Therapeutics IncEWTX | 13 | Buy | $52.00 | +32.82% | Maintains | a month ago |
Jade Biosciences IncJBIO | 9 | Buy | $45.00 | +106.33% | Maintains | a month ago |
Solid Biosciences IncSLDB | 7 | Buy | $16.00 | +56.86% | Reiterates | a month ago |
Larimar Therapeutics IncLRMR | 7 | Buy | $12.00 | +273.83% | Maintains | a month ago |
Alto Neuroscience IncANRO | 7 | Hold | $24.00 | -3.77% | Maintains | 2 months ago |
Pepgen IncPEPG | 15 | Buy | $4.00 | +120.99% | Maintains | 2 months ago |
Ultragenyx Pharmaceutical IncRARE | 16 | Hold | $26.00 | -19.70% | Maintains | 2 months ago |
Denali Therapeutics IncDNLI | 11 | Buy | $23.00 | -11.47% | Maintains | 2 months ago |
Biocryst Pharmaceuticals IncBCRX | 2 | Buy | $21.00 | +117.62% | Maintains | 2 months ago |
Dianthus Therapeutics IncDNTH | 15 | Buy | $105.00 | +16.40% | Maintains | 2 months ago |
Neurocrine Biosciences IncNBIX | 13 | Buy | $176.00 | +4.91% | Maintains | 2 months ago |
Sionna Therapeutics IncSION | 1 | Buy | $53.00 | +27.28% | Initiates Coverage On | 2 months ago |
Biogen IncBIIB | 18 | Hold | $196.00 | -6.55% | Maintains | 2 months ago |
Ovid Therapeutics IncOVID | 4 | Buy | $7.00 | +161.19% | Reiterates | 3 months ago |
Pharvaris NvPHVS | 9 | Buy | $42.00 | +23.71% | Maintains | 3 months ago |
Stoke Therapeutics IncSTOK | 11 | Buy | $38.00 | +16.17% | Maintains | 3 months ago |
Xenon Pharmaceuticals IncXENE | 11 | Buy | $63.00 | +4.48% | Maintains | 4 months ago |
Maze Therapeutics IncMAZE | 3 | Buy | $58.00 | +94.57% | Maintains | 4 months ago |
Apellis Pharmaceuticals IncAPLS | 14 | Hold | $18.00 | -56.13% | Maintains | 4 months ago |
Gossamer Bio IncGOSS | 7 | Hold | $1.00 | +495.24% | Downgrades | 4 months ago |
Ardelyx IncARDX | 16 | Buy | $19.00 | +268.22% | Reiterates | 4 months ago |
Vera Therapeutics IncVERA | 9 | Hold | $33.00 | -22.64% | Maintains | 7 months ago |
Astria Therapeutics IncATXS | 10 | Hold | $13.00 | +3.34% | Downgrades | 9 months ago |
Tourmaline Bio IncTRML | 3 | Hold | $48.00 | +0.04% | Downgrades | 10 months ago |
Vigil Neuroscience IncVIGL | 11 | Hold | $8.00 | N/A | Downgrades | a year ago |
Sage Therapeutics IncSAGE | 7 | Hold | $6.00 | N/A | Reiterates | a year ago |
Longboard Pharmaceuticals IncLBPH | 7 | Buy | $44.00 | N/A | Maintains | 2 years ago |
Voyager Therapeutics IncVYGR | 3 | Hold | $7.00 | N/A | Maintains | 2 years ago |
Rallybio CorpRLYB | 4 | Buy | $88.00 | N/A | Maintains | 2 years ago |
Design Therapeutics IncDSGN | 5 | Hold | $5.00 | N/A | Reiterates | 2 years ago |
Karuna Therapeutics IncKRTX | 4 | Hold | $330.00 | N/A | Downgrades | 3 years ago |
Chinook Therapeutics IncKDNY | 3 | Hold | $42.00 | N/A | Downgrades | 3 years ago |
Impel Pharmaceuticals IncIMPLQ | 2 | Hold | $5.00 | N/A | Downgrades | 4 years ago |
Taysha Gene Therapies IncTSHA | 2 | Buy | $5.00 | N/A | Maintains | 4 years ago |
Biohaven Pharmaceutical Holding Co LtdBHVN1 | 1 | Hold | $148.50 | N/A | Downgrades | 4 years ago |
Viela Bio IncVIE | 2 | Hold | N/A | N/A | Downgrades | 5 years ago |
Biomarin Pharmaceutical IncBMRN | 3 | Buy | $110.00 | N/A | Reinstates | 7 years ago |
Acer Therapeutics IncACER | 2 | Buy | $40.00 | N/A | Reinstates | 7 years ago |
Paratek Pharmaceuticals IncPRTK | 2 | Buy | N/A | N/A | Downgrades | 8 years ago |
Bioverativ IncBIVV | 1 | Hold | N/A | N/A | Downgrades | 8 years ago |
Corbus Pharmaceuticals Holdings IncCRBP | 1 | Buy | $720.00 | N/A | Initiates Coverage On | 8 years ago |
Cidara Therapeutics IncCDTX | 1 | Strong Buy | $280.00 | N/A | Initiates Coverage On | 9 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.